Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07273149 · ClinicalTrials.gov registry record · NA
A Study to Assess the Effectiveness of a Marketed Denture Adhesive in Real-World Setting
A NA study of Denture Retention, sponsored by HALEON.
- Recruiting
- Registry status
- NA
- Development phase
- 375
- Enrollment target
- 1
- Study location
NCT07273149: Recruiting NA study of Denture Retention, sponsored by HALEON.
NCT07273149 is a NA study of Denture Retention that is actively recruiting participants, run by HALEON. The registered enrollment target is 375 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07273149, a NA study of Denture Retention, is actively recruiting participants, sponsored by HALEON.
- RECRUITING
- Registry status
- NA
- Development phase
- 375 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this decentralised study in a real-world setting is to assess the effectiveness of a marketed denture adhesive (Poligrip Power Max Hold + Seal) in preventing food entrapment under dentures (self-assessed). The study will evaluate participants perceived food occlusion of a marketed denture adhesive over three weeks compared to no adhesive use over three weeks in a real-world setting.
Primary Outcome
Participants will answer specific food related question on a daily basis throughout the study. Participants scored the Food Occlusion Question using the NRS.
Conditions Studied
Interventions
- DEVICE Poligrip Power Max Hold + Seal
Study Locations (1)
Massachusetts
- Lindus Health (virtual site) - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 375 participants |
| Start Date | 2025-12-05 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT07273149 shows while recruiting
NCT07273149 is an interventional study that assigns participants to a tested intervention. The registered 375 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Denture Retention appearing as the primary indexed condition, and to 1 intervention - of which Poligrip Power Max Hold + Seal is the first listed.
NCT07273149 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07273149 about?
NCT07273149 is a clinical study titled "A Study to Assess the Effectiveness of a Marketed Denture Adhesive in Real-World Setting". The purpose of this decentralised study in a real-world setting is to assess the effectiveness of a marketed denture adhesive (Poligrip Power Max Hold + Seal) in preventing food entrapment under dentures (self-assessed). The study will evaluate participants perceived food occlusion of a marketed den...
What is the current status of trial NCT07273149?
This trial is currently recruiting. It is a NA study. The enrollment target is 375 participants. The study started on 2025-12-05. Estimated completion is 2026-04.
What conditions does trial NCT07273149 study?
This clinical trial studies the following conditions: Denture Retention.
What interventions are being tested in trial NCT07273149?
The interventions under investigation include: Poligrip Power Max Hold + Seal (DEVICE).
Who is sponsoring clinical trial NCT07273149?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07273149 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Denture Retention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07273149's enrollment target sits among peer trials
375 276th of 2000 higher than 1,721 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03686124 · 375 participants · Phase 1
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- NCT04059172 · 375 participants · Early Phase 1
Efficacy of Combined Ibuprofen and Acetaminophen Therapy Versus Ibuprofen Alone Versus Placebo Alone for Pain Management
- NCT04134923 · 375 participants
Imaging Biomarkers in Preclinical and Symptomatic AD
- NCT04569747 · 375 participants · Phase 2
A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI